ArticleGeroScience2026
The combined association between sleep duration and insomnia symptoms with dementia and cognitive deficits: a multivariable-adjusted and genetic liability study.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Insomnia symptoms in combination with extreme habitual sleep durations may be associated with long-term dementia incidence, which we explored using multivariable-adjusted regression and genetic association analyses in Europeans. European-ancestry participants free of baseline dementia (N = 422,106; 5288 new cases over 12.7 years follow-up) from UK Biobank were stratified into six groups based on the combination of self-reported insomnia symptoms (no/yes) and short (4-6 h), average (7-8 h), and long (9-14 h) sleep duration. We assessed their associations with incident dementia and baseline cognitive function by multivariable-adjusted regression models. In addition, we grouped participants based on the combination of genetic scores for sleep duration and insomnia symptoms, and repeated the analyses accordingly. Compared to participants reporting no insomnia symptoms and average sleep duration at baseline, both long (hazard ratio 1.27, 95% confidence interval [1.15, 1.39]) and short (1.19 [1.09, 1.30]) sleep duration without concomitant insomnia symptoms were associated with increased dementia risk. Similarly, both short and long sleep duration, stratified by concomitantly reported insomnia symptoms, were associated with reduced function in different cognitive domains. Conversely, the genetic risk of insomnia symptoms, and not sleep duration, was associated with dementia (OR = 1.07 [1.02, 1.13]) and prospective memory result (OR = 1.07 [1.02, 1.14]). We observed no evidence for synergism between sleep duration and insomnia symptoms on the study outcomes. In conclusion, while long sleep duration was associated with both incident dementia and different cognitive domains, no such evidence was obtained from the genetic analyses, indicating the potential of disturbed sleep as a marker of future dementia rather than a causal risk factor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.